Inductors for Rapid Sequence Intubation Summary Table
(Updated April 2022)
Comment: dosing in the obese
The optimal dosing adjustments in obese patients are still on debate and authors support different modalities. Those recommended in the table represent the most frequently accepted corrections by the literature and we also agree on those corrections based on our own clinical experience in emergency medicine. For more information follow this link.
TBW Total body weight
IBW Ideal body weight
NMDA N-methyl-D-aspartate (receptor)
RSI Rapid Sequence Intubation
References
Brunette DD. Resuscitation of the morbidly obese patient [published correction appears in Am J Emerg Med. 2004 May;22(3):248]. Am J Emerg Med. 2004;22(1):40-47. doi:10.1016/s0735-6757(02)42250-4.
Pubmed
Miller, Ronald D. Miller's Anesthesia. 8th edition. Philadelphia, PA: Churchill Livingstone/Elsevier; 2015.
Elsevier
Brown CA, Sakles JC, Mick NW. The Walls Manual of Emergency Airway Management. 5th edition. Philadelphia, PA. Wolters Kluwer; 2018.
Wolters KluwerCabrera JL, Auerbach JS, Merelman AH, Levitan RM. The High-Risk Airway. Emerg Med Clin North Am. 2020;38(2):401-417. doi:10.1016/j.emc.2020.01.008.
Pubmed
Manning S. The Crashing Obese Patient. Emerg Med Clin North Am. 2020;38(4):857-869. doi:10.1016/j.emc.2020.06.013.
Pubmed
Erstad BL, Barletta JF. Drug dosing in the critically ill obese patient-a focus on sedation, analgesia, and delirium. Crit Care. 2020;24(1):315. Published 2020 Jun 8. doi:10.1186/s13054-020-03040-z.
Pubmed
® 2023 EMDrugs. All rights reserved.
contact@emdrugs.com
DISCLAIMER
⚠ This website provides general information and discussion about medications, health, and related subjects. The words and other content provided in this website, and in any linked materials, are not intended and should not be construed as medical advice. If the reader or any other person has a medical concern, he or she should consult with an appropriately-licensed physician or other legally accredited health care worker in the country that resides or is visiting.
Please do not delay your medical concerns and potential health emergencies by searching information in this website, instead look out for medical opinion in the services that exist with that specific purpose and work under the respective local health-care regulations.
The views expressed on this blog and website have no relation to those of any academic, hospital, practice or other institution with which the authors are affiliated.
For other instances, the authors of this website do not have any conflict of interest with any institution or pharmaceutical company in particular, and do not receive any compensation about any licenced drug mentioned in the website. In the same matter, the website is not intended to recommend any specific patented medication.
EMDrugs Team